发明授权
EP1370554B1 3-(4-AMIDOPYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS
有权
3-（4-氨基吡咯-2-基）甲基）-2-吲哚啉衍生物ALS蛋白激酶抑制剂
- 专利标题： 3-(4-AMIDOPYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS
- 专利标题（中）： 3-（4-氨基吡咯-2-基）甲基）-2-吲哚啉衍生物ALS蛋白激酶抑制剂
-
申请号： EP02714897.2申请日： 2002-02-15
-
公开(公告)号： EP1370554B1公开(公告)日： 2005-10-19
- 发明人: GUAN, Huiping , LIANG, Congxin , SUN, Li , TANG, Peng, Cho , WEI, Chung, Chen , MAURAGIS, Michael, A. , VOJKOVSKY, Tomas , JIN, Qingwu , HERRINTON, Paul, Matthew
- 申请人： Pharmacia & Upjohn Company LLC , Sugen, Inc.
- 申请人地址： 301 Henrietta Street Kalamazoo, MI 49001 US
- 专利权人： Pharmacia & Upjohn Company LLC,Sugen, Inc.
- 当前专利权人： Pharmacia & Upjohn Company LLC,Sugen, Inc.
- 当前专利权人地址： 301 Henrietta Street Kalamazoo, MI 49001 US
- 代理机构： Viering, Jentschura & Partner
- 优先权： US268683P 20010215; US312361P 20010815
- 国际公布： WO2002066463 20020829
- 主分类号： C07D403/06
- IPC分类号： C07D403/06 ; C07D403/14 ; C07D471/04 ; A61K31/404 ; A61K31/4166 ; A61K31/437 ; A61K31/5377 ; A61K31/541 ; A61P35/00
摘要：
The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
公开/授权文献
信息查询
